Beijing Sl Pharmaceutical Co.,Ltd.’s Net Profit Dropped 45.8% in 2022

Beijing Sl Pharmaceutical Co.,Ltd. (北京双鹭药业股份有限公司) (002038.SZ) reported a net profit of 228.3 million yuan in 2022, down 45.8% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, down 13.6% year-on-year.

At the end of the reporting period, it had 5.9 billion yuan in total assets and 396.6 million yuan in total liabilities, with a liability-to-asset ratio of 6.8%.